Genome-wide interaction analysis identified low-frequency variants with sex disparity in lung cancer risk.


Journal

Human molecular genetics
ISSN: 1460-2083
Titre abrégé: Hum Mol Genet
Pays: England
ID NLM: 9208958

Informations de publication

Date de publication:
23 08 2022
Historique:
received: 06 08 2021
revised: 14 01 2022
accepted: 31 01 2022
pubmed: 10 2 2022
medline: 27 8 2022
entrez: 9 2 2022
Statut: ppublish

Résumé

Differences by sex in lung cancer incidence and mortality have been reported which cannot be fully explained by sex differences in smoking behavior, implying existence of genetic and molecular basis for sex disparity in lung cancer development. However, the information about sex dimorphism in lung cancer risk is quite limited despite the great success in lung cancer association studies. By adopting a stringent two-stage analysis strategy, we performed a genome-wide gene-sex interaction analysis using genotypes from a lung cancer cohort including ~ 47 000 individuals with European ancestry. Three low-frequency variants (minor allele frequency < 0.05), rs17662871 [odds ratio (OR) = 0.71, P = 4.29×10-8); rs79942605 (OR = 2.17, P = 2.81×10-8) and rs208908 (OR = 0.70, P = 4.54×10-8) were identified with different risk effect of lung cancer between men and women. Further expression quantitative trait loci and functional annotation analysis suggested rs208908 affects lung cancer risk through differential regulation of Coxsackie virus and adenovirus receptor gene expression in lung tissues between men and women. Our study is one of the first studies to provide novel insights about the genetic and molecular basis for sex disparity in lung cancer development.

Identifiants

pubmed: 35138370
pii: 6524820
doi: 10.1093/hmg/ddac030
pmc: PMC9402242
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2831-2843

Subventions

Organisme : NCI NIH HHS
ID : R35 CA197449
Pays : United States
Organisme : NCI NIH HHS
ID : U19 CA203654
Pays : United States
Organisme : NIEHS NIH HHS
ID : R24 ES028527
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA167462
Pays : United States
Organisme : NCI NIH HHS
ID : R21 CA235464
Pays : United States
Organisme : NIEHS NIH HHS
ID : P30 ES030285
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA015083
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA243483
Pays : United States
Organisme : NCI NIH HHS
ID : UM1 CA167462
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA076292
Pays : United States

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press.

Références

Nat Commun. 2018 Aug 13;9(1):3221
pubmed: 30104567
Stat Med. 1997 Aug 15;16(15):1731-43
pubmed: 9265696
Am J Epidemiol. 2000 Aug 1;152(3):197-203
pubmed: 10933265
Int J Epidemiol. 1984 Sep;13(3):356-65
pubmed: 6386716
Nat Genet. 2012 Dec;44(12):1330-5
pubmed: 23143601
Carcinogenesis. 2018 Mar 8;39(3):336-346
pubmed: 29059373
Am J Epidemiol. 1996 Aug 1;144(3):207-13
pubmed: 8686689
Am J Epidemiol. 1997 Nov 1;146(9):713-20
pubmed: 9366618
Nat Genet. 2022 Aug;54(8):1167-1177
pubmed: 35915169
Am J Epidemiol. 2009 Jan 15;169(2):219-26
pubmed: 19022827
Carcinogenesis. 2016 Jan;37(1):96-105
pubmed: 26590902
Cancer Epidemiol Biomarkers Prev. 2017 Jan;26(1):126-135
pubmed: 27697780
Cancer Cell. 2016 May 9;29(5):711-722
pubmed: 27165743
BMC Med. 2020 Mar 23;18(1):71
pubmed: 32200763
Int J Cancer. 2017 Jul 15;141(2):309-323
pubmed: 28440542
BMC Public Health. 2008 Jun 06;8:203
pubmed: 18538025
Br Med J. 1980 Apr 5;280(6219):967-71
pubmed: 7417764
Genet Epidemiol. 2013 Sep;37(6):603-13
pubmed: 23873611
Hum Mol Genet. 2016 Feb 1;25(3):620-9
pubmed: 26732429
Nat Genet. 2009 Aug;41(8):882-4
pubmed: 19561607
BMC Med Genomics. 2015;8 Suppl 1:S2
pubmed: 25951849
Am J Hum Genet. 2019 Jan 3;104(1):65-75
pubmed: 30595370
Bioinformatics. 2002 Feb;18(2):333-4
pubmed: 11847087
Proc Biol Sci. 2019 Jun 12;286(1904):20190660
pubmed: 31161912
Medicine (Baltimore). 2017 Nov;96(46):e8816
pubmed: 29145344
Ulster Med J. 2008 Jan;77(1):31-5
pubmed: 18269115
Cell Rep. 2020 Jun 23;31(12):107795
pubmed: 32579922
Front Genet. 2014 Jun 19;5:187
pubmed: 24995013
Am J Epidemiol. 2009 Feb 15;169(4):497-504
pubmed: 19074774
Genome Res. 2012 Sep;22(9):1790-7
pubmed: 22955989
PLoS Genet. 2014 Jan 30;10(1):e1004102
pubmed: 24497837
Eur J Epidemiol. 2017 Aug;32(8):701-710
pubmed: 28624884
Stat Med. 1994 Jan 30;13(2):153-62
pubmed: 8122051
J Natl Cancer Inst. 1996 Feb 21;88(3-4):183-92
pubmed: 8632492
Am J Hum Genet. 2013 Nov 7;93(5):779-97
pubmed: 24210251
BMC Biol. 2017 Feb 7;15(1):7
pubmed: 28173793
Nat Genet. 2017 Jul;49(7):1126-1132
pubmed: 28604730
Biol Psychiatry. 2019 Jun 1;85(11):946-955
pubmed: 30679032
Nucleic Acids Res. 2019 Jan 8;47(D1):D886-D894
pubmed: 30371827
Oncotarget. 2016 May 10;7(19):27313-24
pubmed: 27036026
Natl Cancer Inst Monogr. 1966 Jan;19:127-204
pubmed: 5905667
Nature. 2014 Mar 20;507(7492):371-5
pubmed: 24646999
Biochim Biophys Acta. 2014 Oct;1842(10):1910-1922
pubmed: 24667321
Front Oncol. 2019 Nov 20;9:1230
pubmed: 31824839
Cancer Causes Control. 2019 Nov;30(11):1259-1268
pubmed: 31468279
Genome Biol Evol. 2016 Jun 02;8(5):1489-500
pubmed: 27189992
N Engl J Med. 2018 May 24;378(21):1999-2009
pubmed: 29791813

Auteurs

Yafang Li (Y)

Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX 77030, USA.
Section of Epidemiology and Population Sciences, Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA.

Xiangjun Xiao (X)

Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX 77030, USA.

Jianrong Li (J)

Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX 77030, USA.

Jinyoung Byun (J)

Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX 77030, USA.
Section of Epidemiology and Population Sciences, Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.

Chao Cheng (C)

Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX 77030, USA.
Section of Epidemiology and Population Sciences, Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA.

Yohan Bossé (Y)

Institut universitaire de cardiologie et de pneumologie de Québec, Department of Molecular Medicine, Laval University, Quebec City G1V 4G5, Canada.

James McKay (J)

Section of Genetics, International Agency for Research on Cancer, World Health Organization, Lyon 69372, France.

Demetrios Albanes (D)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20850, USA.

Stephen Lam (S)

Department of Integrative Oncology, University of British Columbia, Vancouver, BC V5Z 1L3, Canada.

Adonina Tardon (A)

Public Health Department, University of Oviedo, ISPA and CIBERESP, Asturias 33003, Spain.

Chu Chen (C)

Program in Epidemiology, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

Stig E Bojesen (SE)

Department of Clinical Biochemistry, Copenhagen University Hospital, Copenhagen 2600, Denmark.
Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen 2177, Denmark.

Maria T Landi (MT)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20850, USA.

Mattias Johansson (M)

Section of Genetics, International Agency for Research on Cancer, World Health Organization, Lyon 69372, France.

Angela Risch (A)

Thoraxklinik at University Hospital Heidelberg, Heidelberg 69126, Germany.
Translational Lung Research Center Heidelberg (TLRC-H), Heidelberg 69120, Germany.
University of Salzburg and Cancer Cluster Salzburg, 5020, Austria.

Heike Bickeböller (H)

Department of Genetic Epidemiology, University Medical Center, Georg-August-University Göttingen, 37099, Germany.

H-Erich Wichmann (HE)

Institute of Medical Statistics and Epidemiology, Technical University Munich, 80333, Germany.

David C Christiani (DC)

Departments of Environmental Health and Epidemiology, Harvard TH Chan School of Public Health, Boston, MA 02115, USA.

Gad Rennert (G)

Clalit National Cancer Control Center at Carmel Medical Center and Technion Faculty of Medicine, Haifa 3436212, Israel.

Susanne Arnold (S)

University of Kentucky, Markey Cancer Center, Lexington, Kentucky 40536, USA.

Gary Goodman (G)

Swedish Cancer Institute, Seattle, WA 98104, USA.

John K Field (JK)

Institute of Translational Medicine, University of Liverpool, Liverpool L69 7BE, United Kingdom.

Michael P A Davies (MPA)

Institute of Translational Medicine, University of Liverpool, Liverpool L69 7BE, United Kingdom.

Sanjay S Shete (SS)

Department of Biostatistics, The University of Texas, M.D. Anderson Cancer Center, Houston, TX 77030, USA.
Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Loic Le Marchand (L)

Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI 96813, USA.

Olle Melander (O)

Faculty of Medicine, Lund University, Lund 22184, Sweden.

Hans Brunnström (H)

Faculty of Medicine, Lund University, Lund 22184, Sweden.

Geoffrey Liu (G)

University Health Network- The Princess Margaret Cancer Centre, Toronto, CA ON, M5G 2C1, Canada.

Rayjean J Hung (RJ)

Luenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto ON, M5G 1X5, Canada.
Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto ON, M5T 3M7, Canada.

Angeline S Andrew (AS)

Departments of Epidemiology and Community and Family Medicine, Dartmouth College, Hanover, NH 03755, USA.

Lambertus A Kiemeney (LA)

Radboud University Medical Center, Nijmegen 6525, The Netherlands.

Hongbing Shen (H)

Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing 211166, P.R. China.

Ryan Sun (R)

Department of Biostatistics, The University of Texas, M.D. Anderson Cancer Center, Houston, TX 77030, USA.

Shan Zienolddiny (S)

National Institute of Occupational Health, Oslo 0304, Norway.

Kjell Grankvist (K)

Department of Medical Biosciences, Umeå University, Umeå 901 87, Sweden.

Mikael Johansson (M)

Department of Radiation Sciences, Umeå University, Umeå 901 87, Sweden.

Neil Caporaso (N)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20850, USA.

Dawn M Teare (DM)

Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, NE2 4AX, UK.

Yun-Chul Hong (YC)

Department of Preventive Medicine, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.

Philip Lazarus (P)

Department of Pharmaceutical Sciences, College of Pharmacy, Washington State University, Spokane, Washington 99202, USA.

Matthew B Schabath (MB)

Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.

Melinda C Aldrich (MC)

Department of Thoracic Surgery, Division of Epidemiology, Vanderbilt University Medical Center Nashville, TN 37232, USA.

Ann G Schwartz (AG)

Department of Oncology, Wayne State University School of Medicine, Detroit, MI 48201, USA.
Karmanos Cancer Institute, Detroit, MI 48201, USA.

Ivan Gorlov (I)

Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX 77030, USA.
Section of Epidemiology and Population Sciences, Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA.

Kristen Purrington (K)

Karmanos Cancer Institute, Detroit, MI 48201, USA.

Ping Yang (P)

Division of Epidemiology, Department of Health Sciences Research, Mayo Clinics Rochester, MN, 55905, USA.

Yanhong Liu (Y)

Section of Epidemiology and Population Sciences, Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA.

Younghun Han (Y)

Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX 77030, USA.
Section of Epidemiology and Population Sciences, Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.

Joan E Bailey-Wilson (JE)

National Human Genome Research Institute, NIH, Baltimore, MD 20892, USA.

Susan M Pinney (SM)

University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA.

Diptasri Mandal (D)

Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA.

James C Willey (JC)

College of Medicine and Life Sciences, University of Toledo, Toledo, OH 43614, USA.

Colette Gaba (C)

The University of Toledo College of Medicine, Toledo, OH 43614, USA.

Paul Brennan (P)

Section of Genetics, International Agency for Research on Cancer, World Health Organization, Lyon 69372, France.

Christopher I Amos (CI)

Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX 77030, USA.
Section of Epidemiology and Population Sciences, Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH